… This analysis explored the prognostic importance of heart rate in patients with heart failure
with reduced ejection fraction in randomized controlled trials comparing beta-blockers and …

… the most effective control of heart rate are associated with a … , suggesting that effective
control of heart rate is important for … of β-blockers does not reliably decrease heart rates, and …

… In the present study, we found that mortality was highest in patients without beta blocker
treatment irrespective of underlying HR. Our data, therefore, support the use of beta blockers in …

… To the contrary, the results of the present analyses show that reduction of heart rate with
beta-blocker therapy is associated with increased risk of cardiovascular events. …

… the narrow range of heart rate reduction values in the included trials limit our ability to
speculate about the “optimal” magnitude of heart rate reduction to aim for with β-blocker therapy. …

… suggest that treatment to reduce resting heart rate in patients with heart failure to <65 bpm
is associated with a better prognosis. However, risk must increase with very low heart rates. …

… of them are unable to tolerate beta blockers. Ivabradine may thus be a useful medicine in
therapeutic heart rate management especially in patients who are intolerant of beta-blockers. …

… least 50% guideline-directed medical therapy beta-blocker dose and heart rate ≥70 vs. <70 …
heart rate despite being on at least 50% guideline-directed medical therapy beta-blocker …

… AMI shifts cardiovascular autonomic control of heart rate in a … β blockers on HRV and are
additive and not redundant. Thus, it is reasonable to suggest the combination β-blocker therapy …

… -controlled trial evaluating the antiischemic efficacy of specifically tailored beta-blocker
therapy to control individual patient heart rate … heart rate at which preoperative Holter monitor …